Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer

Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer

Abstract Background As one of the many breast cancer subtypes, human epidermal growth factor receptor 2 (Her2)-positive breast cancer has higher invasiveness and poor prognosis, although the advent of anti-Her2 drugs has brought good news to patients. However, the emergence of drug resistance still...

Full description

Bibliographic Details
Main Authors: Chundi Gao, Jing Zhuang, Huayao Li, Cun Liu, Chao Zhou, Lijuan Liu, Fubin Feng, Changgang Sun, Jibiao Wu
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Cancer Cell International
Subjects:
Her2-positive breast cancer
Prognostic risk scoring system
Lasso Cox regression analysis
Copy number variation
Survival analysis
Online Access:http://link.springer.com/article/10.1186/s12935-020-01175-1

Internet

http://link.springer.com/article/10.1186/s12935-020-01175-1

Similar Items